Clinical and endoscopic evaluation of the progression of gastroesophageal reflux disease (GERD) in patients successfully treated with esomeprazole as basis for epidemiological long-term follow-up.
Gastroesophageal Reflux Disease
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
No locations available